4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-021350
CHIEF EXECUTIVE OFFICER sold 40,000 shares at $55.25 ($2,210,040)
- CHIEF EXECUTIVE OFFICER acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-08-07 | Option exercise 10b5-1 | +40,000 | $2.94 | $117,440 | 178,641 | D |
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-08-07 | Sale 10b5-1 | −40,000 | $55.25 | $2,210,040 | 138,641 | D |
| Derivatives | |||||||
| Peetz Christopher CHIEF EXECUTIVE OFFICER | 2025-08-07 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −40,000 | 198,487 | D | ||
| Open-market sales · 40,000 sh · avg $55.25 · $2,210,040 | |||||||
Loading xslF345X05/form4-08082025_080828.xml…